Dermata Therapeutics (DRMA) Shares Issued (2020 - 2026)
Dermata Therapeutics (DRMA) posted quarterly Shares Issued of $167477.0 for Q1 2026, down 18.24% year-over-year from $204841.0 in Q1 2025, and up 717.88% quarter-over-quarter from $20477.0 in Q4 2025.
Dermata Therapeutics (DRMA) Shares Issued (2020 - 2026) Analysis & Trends
Dermata Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $167477.0 for Q1 2026.
- In Q1 2026, Shares Issued fell 18.24% year-over-year to $167477.0; the TTM figure through Mar 2026 stood at $167477.0 (down 18.24% YoY), while the FY2025 annual figure was $20477.0, up 291.75% from the prior year.
- Shares Issued for Q1 2026 stood at $167477.0, up from $20477.0 in the prior quarter.
- The five-year high for Shares Issued was $8.4 million in Q1 2024, with the low at $1955.0 in Q2 2024.
- The 5-year median for Shares Issued is $57461.5 (2022), against an average of $872275.1.
- The sharpest annual moves came in 2023 and 2024: Shares Issued surged 1673.2% in 2023, then plunged 99.82% in 2024.
- Dermata Therapeutics' Shares Issued stood at $65983.0 in 2022, then plunged by 89.75% to $6763.0 in 2023, then retreated by 22.71% to $5227.0 in 2024, then surged by 291.75% to $20477.0 in 2025, then soared by 717.88% to $167477.0 in 2026.
- Business Quant data shows DRMA's Shares Issued at $167477.0 in Q1 2026, $20477.0 in Q4 2025, and $20477.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | - |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | - |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Dermata Therapeutics | 5.33 Mn | 5.33 Mn | - | 167,477.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 167,477.00 |
| Mar 31, 2026 | 167,477.00 |
| Dec 31, 2025 | 20,477.00 |
| Dec 31, 2025 | 20,477.00 |
| Sep 30, 2025 | 20,477.00 |
| Sep 30, 2025 | 20,477.00 |
| Jun 30, 2025 | 20,477.00 |
| Jun 30, 2025 | 20,477.00 |
| Mar 31, 2025 | 204,841.00 |
| Mar 31, 2025 | 204,841.00 |
| Dec 31, 2024 | 5,227.00 |
| Dec 31, 2024 | 5,227.00 |
| Sep 30, 2024 | 52,341.00 |
| Sep 30, 2024 | 52,341.00 |
| Jun 30, 2024 | 1,955.00 |
| Jun 30, 2024 | 1,955.00 |
| Mar 31, 2024 | 8.36 Mn |
| Mar 31, 2024 | 8.36 Mn |
| Dec 31, 2023 | 6,763.00 |
| Dec 31, 2023 | 6,763.00 |